The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population
Our objective was to determine: 1) whether the checkpoint kinase 2 (CHEK2) del5395 (g.27417113-27422508 del, NC_000022.11) is a founder mutation in the Latvian population, 2) if there is an association between CHEK2 del5395 mutation and cancer risk, and 3) and whether the CHEK2 del5395 mutation impa...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2015-12-01
|
| Series: | Balkan Journal of Medical Genetics |
| Subjects: | |
| Online Access: | http://www.degruyter.com/view/j/bjmg.2015.18.issue-2/bjmg-2015-0083/bjmg-2015-0083.xml?format=INT |